Alcohol is not automatically prohibited with tirzepatide, but avoiding it is safest. As of ****, U.S. prescribing information for Mounjaro and Zepbound does not list alcohol as a contraindication or named drug interaction. In Zepbound trials, nausea affected about 25% to 29% of participants taking 5 mg to 15 mg, while vomiting affected about 8% to 13%.
Some adults may tolerate a small amount of alcohol while taking tirzepatide. Alcohol can also worsen nausea, vomiting, dizziness and dehydration. The risk is greater if you have diabetes, use insulin or a sulfonylurea, are increasing your tirzepatide dose, or already have stomach symptoms.
| Situation | Practical advice |
|---|---|
| Is alcohol formally prohibited? | No. Alcohol is not listed as a contraindication in the current U.S. Mounjaro or Zepbound prescribing information. |
| An occasional small drink | Some adults may tolerate it, preferably with food and water. |
| Nausea, vomiting or diarrhea | Avoid alcohol until the symptoms have stopped. |
| Insulin or sulfonylurea use | Ask your prescriber first because alcohol can add to the risk of low blood sugar. |
| Starting tirzepatide or increasing the dose | Avoid alcohol until you know how your body responds. |
| Severe abdominal pain or repeated vomiting | Stop drinking and seek urgent medical advice. |
Does Tirzepatide Interact Directly With Alcohol?
The current U.S. prescribing information for Mounjaro and Zepbound does not list alcohol as a formal contraindication or named drug interaction. The labels do warn about gastrointestinal side effects, dehydration-related kidney injury, pancreatitis and hypoglycemia.
The labels also identify insulin and insulin-releasing medicines, including sulfonylureas, as medications that can increase the risk of hypoglycemia with tirzepatide.
The NHS advises avoiding alcohol while using tirzepatide because it may worsen nausea and vomiting.
Why Alcohol May Cause Problems With Tirzepatide
Alcohol Can Worsen Nausea, Vomiting and Dehydration
Nausea, diarrhea and vomiting are common side effects of tirzepatide. In Zepbound clinical trials, nausea occurred in approximately 25% to 29% of participants taking 5 mg to 15 mg. Vomiting occurred in approximately 8% to 13%. These side effects were more common during dose escalation.
Alcohol may make stomach symptoms worse. Vomiting or diarrhea after drinking also makes dehydration more likely. The Zepbound label reports cases of acute kidney injury linked to gastrointestinal symptoms that caused volume depletion.
Alcohol Can Contribute to Low Blood Sugar
Alcohol can make it harder for the liver to maintain a steady blood glucose level, especially when you drink without eating. This matters most if you have diabetes or take insulin or a sulfonylurea with tirzepatide.
Low blood sugar can cause sweating, shakiness, dizziness, confusion, drowsiness and difficulty walking. Those symptoms can look like intoxication, which may delay treatment for a low blood sugar episode.
Alcohol and Tirzepatide Both Raise Pancreatitis Concerns
Tirzepatide labeling warns about acute pancreatitis. Symptoms can include severe or persistent abdominal pain that may spread to the back, with or without nausea and vomiting.
Alcohol misuse is also a recognized cause of pancreatitis. One drink combined with tirzepatide has not been shown to cause pancreatitis, but avoiding binge drinking is a sensible precaution.
If You Choose to Drink While Taking Tirzepatide
These steps can reduce the chance of problems:
- Wait until your dose is stable. Avoid alcohol when you first start tirzepatide or soon after a dose increase, when nausea and vomiting are more likely.
- Eat before drinking. Do not drink on an empty stomach or use alcohol in place of a meal.
- Start with no more than one standard drink. In the United States, one standard drink is about 12 ounces of 5% beer, 5 ounces of wine or 1.5 ounces of 80-proof spirits.
- Drink water as well. Skip alcohol if you are vomiting, have diarrhea or cannot keep fluids down.
- Check your blood glucose if you have diabetes. Follow your diabetes care plan and keep fast-acting glucose available.
- Do not change or skip your tirzepatide dose to accommodate alcohol unless your prescriber tells you to.
- Do not drive after drinking. Alcohol impairment and low blood sugar can be difficult to tell apart.
Who Should Avoid Alcohol or Ask a Clinician First?
Speak with your prescriber before drinking if you:
- Take insulin, glipizide, glyburide, glimepiride or another sulfonylurea.
- Have had pancreatitis or gallbladder disease.
- Have persistent nausea, vomiting, diarrhea or severe abdominal pain.
- Have kidney disease or become dehydrated easily.
- Have severe gastroparesis or major problems with stomach emptying.
- Are pregnant, trying to become pregnant or breastfeeding.
- Have difficulty limiting alcohol once you start drinking.
When to Seek Urgent Medical Help
Stop drinking and seek urgent medical care for severe or persistent abdominal pain, especially pain that spreads to the back, repeated vomiting, inability to keep fluids down, fainting, confusion, seizure or difficulty waking.
Severe abdominal pain with nausea or vomiting may indicate pancreatitis. Confusion or loss of consciousness may indicate dangerously low blood sugar.
Bottom Line
Skip alcohol during dose increases and whenever tirzepatide is causing nausea, vomiting or diarrhea. If your prescriber says occasional alcohol is appropriate, start with no more than one standard drink, eat beforehand, drink water and monitor your blood glucose if you have diabetes.